Customs Broker Examination study materials
Customs Broker Examination study resources

Ceramic Mugs: Missing ISF, a Stale POA, and Late Entry Summary

Customs Broker Examination · Put your knowledge to work in context.

All case studies

Ceramic Mugs: Missing ISF, a Stale POA, and Late Entry Summary

On March 3, a vessel carrying 1,200 cartons of ceramic mugs arrives at Los Angeles from Vietnam. The importer of record is Pacific Housewares, Inc.; the entered value is $42,000. Its customs broker, Sierra Logistics, files the entry two days after arrival. Sierra never filed an Importer Security Filing, explaining that the overseas supplier usually handles it. The POA on file was signed by a warehouse coordinator at Pacific Housewares who has since left; the company's CFO never signed a new one. Ceramic mugs are subject to FDA food-contact requirements, but Sierra files the entry without any FDA data. The entry summary is filed 14 working days after release, and the estimated duties are deposited at that time. CBP issues a CF 28 asking for the ISF filing, the POA, and FDA clearance. The broker responds that the shipment was released and the entry summary was filed, so the matter is closed.

1. What ISF obligation applied, who was responsible, and what is the exposure?

Read the worked answer

For vessel cargo, the Importer Security Filing must be transmitted to CBP no later than 24 hours before the merchandise is loaded at the foreign port. The obligation rests on the importer, although the importer may authorize an agent, including the customs broker, to file it.

The supplier's usual practice does not shift the legal responsibility. If Sierra agreed to handle entry, it should have confirmed in writing who would file the ISF and obtained the necessary data before loading. The statement that the supplier "usually handles it" is not evidence that anyone actually filed.

A missing or late ISF can result in liquidated damages of $5,000 per violation, subject to a $10,000 maximum per shipment under CBP's enforcement framework. CBP may apply an initial warning or mitigation depending on the facts, but the broker should not assume a warning. The response that the shipment was released is legally irrelevant: release goes to admissibility, not to whether the security filing was timely.

2. Was Sierra authorized to file the entry? Analyze the POA and the broker's obligations.

Read the worked answer

A customs power of attorney must be in writing and signed by the principal or by an individual with authority to bind the principal. Under 19 CFR 141.31 and 141.32, the broker must obtain and retain the POA and must be satisfied that the signer has authority.

A warehouse coordinator ordinarily lacks authority to appoint a customs broker unless the company has specifically delegated that authority in writing. The fact that the coordinator has left the company makes the defect clearer: the broker cannot rely on a stale authorization from a departed employee. The CFO's failure to sign a new POA means Sierra did not have a valid, current authorization on file.

The broker should have requested a new POA from an authorized corporate officer before filing, verified the signer's title and authority, and updated its records. Filing entry without valid authority undermines the entry and exposes the broker to regulatory action. The fact that CBP released the merchandise does not validate the POA.

3. What are the consequences of the late entry summary and the missing FDA data, and what should Sierra have done?

Read the worked answer

The entry summary is generally due within 10 working days after release. Filing on the 14th working day is late. A late entry summary is a bond condition failure and can lead to liquidated damages, in addition to delaying liquidation and the final accounting for duties.

The missing FDA data is a separate problem. Ceramic mugs are food-contact articles, and FDA entry information is required so FDA can determine whether the shipment is acceptable. CBP release does not equal FDA release. Filing an entry without the FDA data can result in an FDA hold, refusal, or recall, and it undermines the broker's reasonable care.

Sierra should have: filed the ISF on time or confirmed another party had done so; obtained a valid POA before entry; transmitted the FDA data with the entry; and filed the entry summary within 10 working days. On receiving the CF 28, Sierra should have investigated and corrected the record rather than treating release as the end of the matter. A prompt correction and tender of any duty owed would be more persuasive than the response given.